SCHEMBL20726799

SCHEMBL20726799

Fc1ccc(-c2nc(-c3cccc(-c4cc5cccnc5c5ncccc45)c3)nc(-c3cccc(-c4cc5cccnc5c5ncccc45)c3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 3/20 0.44
L3MBTL1 Q9Y468 3/20 0.43
CCR1 P32246 2/20 0.43
CCR8 P51685 2/20 0.43
PIK3CD O00329 1/20 0.42
ABCG2 Q9UNQ0 5/20 0.42
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CDC7 O00311 1/20 0.39
ROCK2 O75116 1/20 0.39
MAP4K4 O95819 1/20 0.39
PIM1 P11309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20726911 0.92 TOP1 (0.48) TOP1L3MBTL1CCR1CCR8ABCG2
SCHEMBL23733857 0.91 TOP1 (0.49) TOP1L3MBTL1CCR1CCR8ABCG2
SCHEMBL20726713 0.90 CCR1 (0.43) TOP1L3MBTL1CCR1CCR8PIK3CD
SCHEMBL20726716 0.89 CCR1 (0.45) TOP1L3MBTL1CCR1CCR8PIK3CD
SCHEMBL20726910 0.89 CCR1 (0.47) TOP1L3MBTL1CCR1CCR8PIK3CD
SCHEMBL20726766 0.87 L3MBTL1 (0.43) TOP1L3MBTL1CCR1CCR8PIK3CD
SCHEMBL20726858 0.85 CCR1 (0.44) L3MBTL1CCR1CCR8PIK3CDALDH1A1
SCHEMBL19009572 0.85 CCR1 (0.44) TOP1L3MBTL1CCR1CCR8PIK3CD
SCHEMBL17720982 0.85 CCR1 (0.44) TOP1L3MBTL1CCR1CCR8PIK3CD
SCHEMBL18806863 0.84 CCR1 (0.58) L3MBTL1CCR1CCR8PIK3CDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3441391-B1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2020-09-02 EP disclosed
US-20190051841-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-02-14 US disclosed
EP-3441391-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME Samsung Display Co., Ltd. (KR) 2019-02-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190051841-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AOC2, CYP1A1, CRY1 TOP1 1086/4885L3MBTL1 370/4885CCR1 2508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.